JP2010509229A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010509229A5 JP2010509229A5 JP2009535417A JP2009535417A JP2010509229A5 JP 2010509229 A5 JP2010509229 A5 JP 2010509229A5 JP 2009535417 A JP2009535417 A JP 2009535417A JP 2009535417 A JP2009535417 A JP 2009535417A JP 2010509229 A5 JP2010509229 A5 JP 2010509229A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- catheter
- tenecteplase
- bfr
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010039185 Tenecteplase Proteins 0.000 claims description 66
- 229960000216 tenecteplase Drugs 0.000 claims description 66
- 238000001631 haemodialysis Methods 0.000 claims description 34
- 230000000322 hemodialysis Effects 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 29
- 241000124008 Mammalia Species 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 230000004872 arterial blood pressure Effects 0.000 claims description 8
- 230000017531 blood circulation Effects 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 239000008227 sterile water for injection Substances 0.000 claims description 4
- 238000011200 topical administration Methods 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims 69
- 230000004064 dysfunction Effects 0.000 claims 3
- 230000007774 longterm Effects 0.000 claims 3
- 239000008228 bacteriostatic water for injection Substances 0.000 claims 2
- 239000008215 water for injection Substances 0.000 claims 2
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86475806P | 2006-11-07 | 2006-11-07 | |
| US60/864,758 | 2006-11-07 | ||
| US98348907P | 2007-10-29 | 2007-10-29 | |
| US60/983,489 | 2007-10-29 | ||
| PCT/US2007/082933 WO2008070353A2 (en) | 2006-11-07 | 2007-10-30 | Tissue plasminogen activator variant uses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010509229A JP2010509229A (ja) | 2010-03-25 |
| JP2010509229A5 true JP2010509229A5 (enExample) | 2011-12-15 |
| JP5871449B2 JP5871449B2 (ja) | 2016-03-01 |
Family
ID=39362326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009535417A Active JP5871449B2 (ja) | 2006-11-07 | 2007-10-30 | 組織プラスミノゲン活性化因子バリアントの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8916148B2 (enExample) |
| EP (1) | EP2086571A2 (enExample) |
| JP (1) | JP5871449B2 (enExample) |
| AR (1) | AR063603A1 (enExample) |
| CA (1) | CA2668347C (enExample) |
| CL (1) | CL2007003211A1 (enExample) |
| PE (2) | PE20120639A1 (enExample) |
| TW (1) | TW200826981A (enExample) |
| UY (1) | UY30693A1 (enExample) |
| WO (1) | WO2008070353A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030206906A1 (en) | 2001-11-26 | 2003-11-06 | Genentech, Inc. | Catheter composition and uses thereof |
| US20070014779A1 (en) * | 2002-11-14 | 2007-01-18 | Genentech, Inc. | Plasminogen activator variant formulations |
| WO2008070353A2 (en) | 2006-11-07 | 2008-06-12 | Genentech, Inc. | Tissue plasminogen activator variant uses |
| EP2654770B1 (en) * | 2010-12-23 | 2018-07-11 | Gennova Biopharmaceuticals Ltd. | Pharmaceutical compositions of tenecteplase |
| GB201415062D0 (en) * | 2014-08-26 | 2014-10-08 | Aplagon Oy | Therapeutic |
| DK3209767T3 (da) * | 2014-10-21 | 2020-11-02 | Gennova Biopharmaceuticals Ltd | Hidtil ukendt oprensningsfremgangsmåde til isolering og kommerciel fremstilling af rekombinant tnk-tpa (tenecteplase) |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI831484A7 (fi) | 1982-05-05 | 1983-11-06 | Genentech Inc | Ihmiskudoksen plasminogeenien aktivaattori. |
| US5000185A (en) | 1986-02-28 | 1991-03-19 | Cardiovascular Imaging Systems, Inc. | Method for intravascular two-dimensional ultrasonography and recanalization |
| US5019096A (en) | 1988-02-11 | 1991-05-28 | Trustees Of Columbia University In The City Of New York | Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same |
| US5270198A (en) | 1988-05-20 | 1993-12-14 | Genentech, Inc. | DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells |
| GB8820945D0 (en) | 1988-09-07 | 1988-10-05 | Smith & Nephew | Medical articles |
| NZ230808A (en) | 1988-10-24 | 1993-04-28 | Squibb & Sons Inc | Pharmaceutical compositions and combinations containing an angiotensin-converting enzyme inhibitor and a thrombolytic agent |
| AU7998091A (en) | 1990-05-17 | 1991-12-10 | Harbor Medical Devices, Inc. | Medical device polymer |
| US5399158A (en) | 1990-05-31 | 1995-03-21 | The United States Of America As Represented By The Secretary Of The Army | Method of lysing thrombi |
| US5363754A (en) | 1991-09-03 | 1994-11-15 | Grainco Queensland Co-Operative Association Limited | Apparatus for preparing animal feedstuff from cotton seed |
| JP3559559B2 (ja) | 1992-06-03 | 2004-09-02 | ジェネンテク，インコーポレイテッド | 向上した治療特性を有する組織プラスミノーゲン活性化因子グリコシル化変異体 |
| US5362754A (en) | 1992-11-12 | 1994-11-08 | Univ. Of Tx Md Anderson Cancer Center | M-EDTA pharmaceutical preparations and uses thereof |
| US5688516A (en) | 1992-11-12 | 1997-11-18 | Board Of Regents, The University Of Texas System | Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices |
| US5849736A (en) | 1993-11-24 | 1998-12-15 | The Dupont Merck Pharmaceutical Company | Isoxazoline and isoxazole fibrinogen receptor antagonists |
| CA2174838A1 (en) | 1993-11-24 | 1995-06-01 | John Wityak | Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| US5885967A (en) | 1994-03-04 | 1999-03-23 | Eli Lilly And Company | Antithrombotic agents |
| US5509896A (en) | 1994-09-09 | 1996-04-23 | Coraje, Inc. | Enhancement of thrombolysis with external ultrasound |
| US5556380A (en) | 1995-04-05 | 1996-09-17 | Duke University | Method for removing fibrin sheaths from catheters |
| US5772640A (en) | 1996-01-05 | 1998-06-30 | The Trustees Of Columbia University Of The City Of New York | Triclosan-containing medical devices |
| AU716005B2 (en) | 1995-06-07 | 2000-02-17 | Cook Medical Technologies Llc | Implantable medical device |
| US5932299A (en) | 1996-04-23 | 1999-08-03 | Katoot; Mohammad W. | Method for modifying the surface of an object |
| US5840733A (en) | 1996-07-01 | 1998-11-24 | Redcell, Canada, Inc. | Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes |
| US5837688A (en) | 1996-11-27 | 1998-11-17 | Gelfand; Mathew I. | Use of thrombolytic reagents for prevention of vascular disease |
| GB9626795D0 (en) | 1996-12-23 | 1997-02-12 | Geistlich Soehne Ag | Combating infection in delivery systems |
| AU5526098A (en) | 1996-12-23 | 1998-07-17 | Biochem Pharma Inc. | Bicyclic thrombin inhibitors |
| US5981826A (en) | 1997-05-05 | 1999-11-09 | Georgia Tech Research Corporation | Poly(vinyl alcohol) cryogel |
| JPH10328293A (ja) | 1997-06-04 | 1998-12-15 | Unitika Ltd | 医療用具及びその製造方法 |
| US6206914B1 (en) | 1998-04-30 | 2001-03-27 | Medtronic, Inc. | Implantable system with drug-eluting cells for on-demand local drug delivery |
| US6166007A (en) | 1998-07-02 | 2000-12-26 | Sodemann; Klaus | Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof |
| US6174537B1 (en) | 1998-09-25 | 2001-01-16 | Becton, Dickinson And Company | Catheter flush solution and method for its use |
| BR0010381A (pt) | 1999-03-11 | 2002-02-05 | Du Pont Pharm Co | Método de tratamento da trombose em um mamìfero, e uso de uma combinação de (i) um inibidor do fator xa, e (ii) um composto selecionado do grupo que consiste em aspirina, tpa, um antagonista gpiib/iiia, heparina de baixo peso molecular e heparina |
| CN1378472A (zh) | 1999-03-11 | 2002-11-06 | 杜邦药品公司 | 通过低分子量肝素与血小板聚集抑制剂间协同作用防治各种血栓栓塞疾病的联合治疗方法 |
| CA2302720C (en) | 1999-03-29 | 2009-07-14 | Ed Geistlich Sohne Ag Fur Chemische Industrie | Anticoagulant/sterilizing compositions and methods |
| US6187768B1 (en) | 1999-06-01 | 2001-02-13 | Becton, Dickinson And Company | Kit for flushing medical devices and method of preparation |
| EP1060747A3 (en) | 1999-06-16 | 2001-12-05 | New York Blood Center, Inc. | Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase |
| US6592564B2 (en) | 1999-07-23 | 2003-07-15 | Vasca, Inc. | Methods and kits for locking and disinfecting implanted catheters |
| US6350251B1 (en) | 2000-01-18 | 2002-02-26 | Biolink Corporation | Biocidal locks |
| US20010031981A1 (en) | 2000-03-31 | 2001-10-18 | Evans Michael A. | Method and device for locating guidewire and treating chronic total occlusions |
| PT1284780E (pt) | 2000-05-10 | 2008-08-18 | Ash Access Technology Inc | Uma solução de controlo de cateter incluindo um fotooxidante |
| AU2001285245A1 (en) | 2000-08-25 | 2002-03-13 | Organ Recovery Systems, Inc. | Methods of thrombolytic organ treatment and repair |
| US20050215978A1 (en) | 2001-05-25 | 2005-09-29 | Ash Stephen R | Method of enhancing catheter patency using a citrate salt catheter lock solution |
| US20030206906A1 (en) | 2001-11-26 | 2003-11-06 | Genentech, Inc. | Catheter composition and uses thereof |
| US20070014779A1 (en) | 2002-11-14 | 2007-01-18 | Genentech, Inc. | Plasminogen activator variant formulations |
| ATE354380T1 (de) | 2003-02-03 | 2007-03-15 | Polaschegg Hans-Dietrich Dr Te | Zusammensetzung zur prävention von infektionen durch subkutane prothesen |
| US7696182B2 (en) | 2004-11-02 | 2010-04-13 | Nd Partners, Llc | Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin |
| US7749529B2 (en) | 2005-02-08 | 2010-07-06 | Ash Access Technology, Inc. | Catheter lock solution comprising citrate and a paraben |
| WO2008070353A2 (en) | 2006-11-07 | 2008-06-12 | Genentech, Inc. | Tissue plasminogen activator variant uses |
-
2007
- 2007-10-30 WO PCT/US2007/082933 patent/WO2008070353A2/en not_active Ceased
- 2007-10-30 EP EP07871279A patent/EP2086571A2/en not_active Ceased
- 2007-10-30 JP JP2009535417A patent/JP5871449B2/ja active Active
- 2007-10-30 US US12/447,838 patent/US8916148B2/en active Active
- 2007-10-30 CA CA2668347A patent/CA2668347C/en active Active
- 2007-11-06 PE PE2011001779A patent/PE20120639A1/es not_active Application Discontinuation
- 2007-11-06 PE PE2007001525A patent/PE20081488A1/es not_active Application Discontinuation
- 2007-11-07 UY UY30693A patent/UY30693A1/es not_active Application Discontinuation
- 2007-11-07 CL CL200703211A patent/CL2007003211A1/es unknown
- 2007-11-07 TW TW096142107A patent/TW200826981A/zh unknown
- 2007-11-07 AR ARP070104960A patent/AR063603A1/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5681276B2 (ja) | 肺高血圧症のための治療 | |
| JP2021193130A (ja) | 抗菌組成物およびその使用 | |
| JP2009172394A (ja) | 心臓および他の器官における虚血−再灌流傷害の軽減のための事後調節 | |
| Chhibber et al. | Anesthesia care for adult live donor hepatectomy: our experiences with 100 cases | |
| US20050215978A1 (en) | Method of enhancing catheter patency using a citrate salt catheter lock solution | |
| JP2002523336A (ja) | クエン酸塩カテーテルロック溶液を使用するカテーテル開存性を高める方法 | |
| Kundra et al. | The effect of inhaled milrinone versus inhaled levosimendan in pulmonary hypertension patients undergoing mitral valve surgery—a pilot randomized double-blind study | |
| JP2020504154A5 (enExample) | ||
| US20100249747A1 (en) | Transdermal venous access locking solution | |
| Haymond et al. | Efficacy of low-dose alteplase for treatment of hemodialysis catheter occlusions | |
| De Gregorio et al. | Citalopram-induced long QT syndrome and torsade de pointes: role for concomitant therapy and disease | |
| Walensi et al. | Mesenteric ischemia-reperfusion injury: clearly improved hemodynamics but only minor protection of the rat small intestine by (sub) therapeutic heparin sodium and enoxaparin doses | |
| US20090285909A1 (en) | Lactate and Calcium Containing Pharmaceutical Composition and Uses Thereof | |
| WO2008070353A3 (en) | Tissue plasminogen activator variant uses | |
| Aytuluk et al. | Tranexamic acid is effective in lower doses with infusion in total knee arthroplasty | |
| Krowka | Hepatopulmonary syndrome and portopulmonary hypertension | |
| BR112014004792B1 (pt) | soluções de bloqueio de acesso venoso transdérmico | |
| Alsaghir et al. | Iloprost in pulmonary hypertension due to sub-massive pulmonary embolism: report of two cases | |
| CN104000809A (zh) | 一种防治冠心病心绞痛的药物组合物及其应用 | |
| Sombolos et al. | Experience with the use of uncuffed double-lumen silicone hemodialysis catheters | |
| EP1847269B1 (de) | Verwendung von Acetylsalicylsäure (ASS) beim Einsatz einer Membranlunge | |
| CN101301307A (zh) | Dft在制备治疗和预防脓毒症药物中的应用 | |
| Wittebole et al. | Early Postoperative ICU Care of the Kidney Transplant Recipient | |
| RU2008112667A (ru) | Способы проведения чрескожного коронарного вмешательства | |
| RU2019142647A (ru) | Способ профилактики тромбоза системно-легочного шунта |